Aktie A0MLEC BIOLARGO, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen BioLargo, Inc. Other OTC

Aktien

A0MLEC

US09065A1007

BLGO

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
BioLargo to Present at The LD Micro Invitational XIV
New Regulations May Be Coming To Combat Dangerous “Forever Chemicals” – This Cleantech Innovator Is Ready
Biolargo Equipment Solutions & Technologies, Inc Appoints Sally Gutierrez to the Board of Directors
BioLargo, Inc. Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment
BioLargo, Inc. announced that it has received $0.815 million in funding
BioLargo's PFAS Removal Technology Lands Drinking Water Treatment Project in New Jersey
BioLargo, Inc. cancelled the transaction announced on December 13, 2022
BioLargo, Inc. announced that it expects to receive $0.815 million in funding
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
BioLargo, Inc. to Present at the LD Micro Main Event XVI
BioLargo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
BioLargo, Inc. Discusses Record-Breaking Financial Results, Innovation-Pipeline Business Model, and More with The Stock Day Podcast
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
0:00:05.7 Dennis Calvert: Today. What's up? Dennis Calvert - Form 8-K
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
BioLargo to Present at the Sequire Investor Summit in Puerto Rico
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
BIOLARGO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0MLEC Aktie
  4. A0MLEC Aktie
  5. Nachrichten BioLargo, Inc.
  6. Andere Sprachen